Clinical Trials Browser

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

NCT07155226 2026-03-18

MOMENTUM

Phase 1/2 Recruiting

84 enrolled

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06802757 2026-02-25

PRISM-TNBC

Phase 2 Recruiting

72 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06541067 2026-01-26

POSALLO

Phase 2 Recruiting

30 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT04294641 2026-01-23

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

Phase 2 Completed

10 enrolled 15 charts

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

NCT04825275 2026-01-23

Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial

Phase EARLY_PHASE1 Terminated

7 enrolled 12 charts

CNS

Brain Neoplasms, Glioblastoma

NCT03828773 2025-12-09

PTX3AML

Phase NA Recruiting

410 enrolled

Other hematologic neoplasm

Aspergillosis, Candidiasis, Mycoses, Leukemia, Myeloid, Acute, Genetic Predisposition to Disease

NCT03763396 2024-03-08

Azoles Targeting Recurrent High Grade Gliomas

Phase EARLY_PHASE1 Not yet recruiting

30 enrolled

CNS

Brain Neoplasms, Glioma, Neoplasms

NCT02203773 2023-05-16

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Phase 1 Terminated

212 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT03796533 2022-02-24

Posa-Pk

Phase NA Unknown

120 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02358499 2020-12-22

Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children

Phase 1 Completed

31 enrolled

Other hematologic neoplasm

Bone Marrow Failure Disorders, Leukemia, Mycoses

NCT02875743 2020-04-02

King's Invasive Aspergillosis Study II

Phase 4 Completed

120 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03760445 2020-01-09

HDM201 Added to CT in R/R or Newly Diagnosed AML

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT00936117 2019-02-27

Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia

Phase 2 Completed

25 enrolled 5 charts

Other hematologic neoplasm

Leukemia, Mycoses, Bone Marrow Neoplasms

NCT01200355 2018-05-07

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

Phase 4 Completed

113 enrolled 12 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03036046 2018-02-15

SAFEGUARDFP

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00686543 2017-04-07

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Phase 4 Completed

75 enrolled 14 charts

Other hematologic neoplasm

Mycoses, Neutropenia, Leukemia, Myeloid, Acute

NCT00750737 2016-09-29

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)

Phase 3 Completed

46 enrolled 6 charts

Other hematologic neoplasm

Invasive Fungal Infections, Hematologic Neoplasms

NCT01901172 2015-08-18

A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole, the Relative Bioavailability of New Formulations of RO5503781 and the Food-Effect on the Pharmacokinetics of RO5503781 in Patients With Solid Tumors

Phase 1 Completed

61 enrolled

Tumor-Agnostic

Neoplasms

Clinical Trials

A Study of BGB-11417 in Participants With Myeloid Malignancies

MOMENTUM

PRISM-TNBC

POSALLO

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial

PTX3AML

Azoles Targeting Recurrent High Grade Gliomas

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Posa-Pk

Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children

King's Invasive Aspergillosis Study II

HDM201 Added to CT in R/R or Newly Diagnosed AML

Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

SAFEGUARDFP

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)

A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole, the Relative Bioavailability of New Formulations of RO5503781 and the Food-Effect on the Pharmacokinetics of RO5503781 in Patients With Solid Tumors